Monthly Archive for: ‘July, 2008’

New Experimental Drug Telcagepant Significantly Improves Migraine With Fewer Side Effects

Merck‚Äôs Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study Oral CGRP Receptor Antagonist Provided Similar Migraine Relief with Fewer Adverse Events Compared to Zolmitriptan BOSTON–(BUSINESS WIRE)–Merck & Co., Inc. today announced that, in a Phase III clinical trial, telcagepant (formerly MK-0974), its investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist, significantly improved relief of migraine …

Read More

Magnetic Stimulation Blocks Migraine Pain

Fri Jun 27, 2008 NEW YORK (Reuters Health) – A hand-held device that painlessly sends a magnetic pulse into the head may offer some migraine sufferers relief, a small study suggests. The device delivers a therapy known as transcranial magnetic stimulation, or TMS. It sparks a magnetic pulse that, when held against a person’s head, creates an electric current among …

Read More

Page 4 of 4«1234